Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Seized from Delhi:...

    Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-05-09T11:30:28+05:30  |  Updated On 9 May 2018 11:30 AM IST
    Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

    New Delhi: The DRI has seized huge quantity of prohibited drugs like Alprazolam and Diazepam among others worth Rs 10 crore from the Foreign Post office (FPO) here.


    These drugs, which are abused as narcotics, were mostly in the form of tablets/capsules and packed in small packets, the Directorate of Revenue Intelligence (DRI) said in a statement issued today.


    These controlled drugs, which were mis-declared as herbal/health products, were destined to numerous overseas buyers located in the US, UK, Cananda and Australia, it said.


    During operations last week, more than 3.5 lakhs tablets of Amphetamine, Lorazepam, Nitrazepam, Zolpidem, Oxycodone, Tramadol, Alprazolam and Diazepam, having street value of more than Rs 10 crore, were seized, the DRI said.


    The Foreign Post Office is very prone to smuggling of prohibited/restricted goods due to less documentation, improper declarations and speedy clearance, it said.


    Shipments through the FPO have been under close watch of the DRI in recent times and the agency has seized similar export consignments of psychotropic substances in November 2016 wherein total seizure was of more than 17 lakh tablet and 11 persons were arrested in multi-location operation at Delhi, Mumbai, Ludhiana and Chandigarh, the statement said.


    The DRI has also been successful in unearthing smuggling network in the import section of the FPO, Delhi and seized steroid worth Rs 15 crore and 32 kgs gold concelaed in readymade garments in August 2017.


    alprazolamDiazepamDirectorate of Revenue IntelligenceDRIDRI seizesdrugsForeign Post officeFPOpsychotropicsmugglingunearthing
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok